Knight Allied Health Care

Who are you cheering for?!

Bring on the game!

The Australian Therapeutic Goods Administration (TGA) has approved Tzield (teplizumab) to delay the onset of stage 3 (symptomatic) .

Stage 2 means two or more islet autoantibodies (early markers) have been detected from a blood test and glucose levels are erratic ( ), but no symptoms are evident.

The progression of type 1 diabetes happens in stages. People with stage 2 T1D will gradually progress to stage 3 T1D, with the experience of symptoms ( , , and losing weight, more often). Elevated glucose levels require insulin treatment. This process can take place over months or years.

Studies of Tzield have proven to slow this progression by an average of 2 years. That's at least two years less of injections and finger pricks.

This is the first new therapy approved for T1D in over 100 years, since the discovery of .

Tzield involves an intravenous (IV) infusion. People must be aged 8 years or older and in stage 2 type 1 diabetes.

Read more on the Breakthrough T1D Australia website:

https://breakthrought1d.org.au/news/tzield-approved-in-australia/

Wear BLUE today for world diabetes day where we give thanks for the invention of insulin.

💚WORLD DIABETES DAY💚 In 1922, at the University of Toronto, scientists went to a hospital ward with children who were comatose and dying from diabetic keto-acidosis. Imagine a room full of parents sitting at the bedside waiting for the inevitable death of their child.

The scientists went from bed to bed and injected the children with the new purified extract - insulin. As they began to inject the last comatose child, the first child injected began to awaken. One by one, all of the children awoke from their diabetic comas. A room of death and gloom, became a place of joy and hope.

The discovery of insulin by Dr. Frederick Banting, Charles Best, James Collip, and John Macleod at the University of Toronto stands as one of the most dramatic breakthroughs in medical history. Before 1922, type 1 diabetes was essentially a death sentence, especially for children, who would waste away despite strict starvation diets.

The first clinical use of insulin in January 1922 transformed the fate of patients almost overnight. That ward of comatose children became a living testament to scientific achievement, within hours, the extract was reversing symptoms once thought irreversible. Parents who had been preparing for funerals were instead embracing their children.

This moment didn’t just save those young lives, it reshaped the future for millions worldwide. Today, insulin remains an essential therapy for people with diabetes, and the events of that day in 1922 are remembered as a turning point from despair to hope in modern medicine.

CQ Diabetes Camp registrations are open, closing end of month so RSVP asap

From 1 March 2025, Dexcom G7 will be available through the NDSS for eligible people.

To access Dexcom G7 through the NDSS, you will need to consult an authorised diabetes health professional to update your CGM access from 1 March 2025.

Find more information here: https://ow.ly/1v3450V3W0C

Have you heard?

The Omnipod® 5 Automated Insulin Delivery System now has TGA Approval in Australia for integration with the following Continuous Glucose Monitors (CGMs): Dexcom G6, Dexcom G7 and FreeStyle Libre 2 Plus!

More information to follow as we approach launch.

Today we celebrate world Diabetes day and give thanks to Dr Banting and Mr Best for their invention of insulin, for without which a lot of us would not have survived past diagnosis. Blue is the colour to wear today. We are wishing you all a happy World Diabetes Day 2024.